PMC:7276974 / 204-366 JSONTXT

{"project":"LitCovid-PMC-OGER-BB","denotations":[{"id":"T6","span":{"begin":64,"end":69},"obj":"SP_6;NCBITaxon:9606"},{"id":"T7","span":{"begin":75,"end":85},"obj":"SP_7"},{"id":"T8","span":{"begin":99,"end":105},"obj":"UBERON:0001969"},{"id":"T9","span":{"begin":122,"end":128},"obj":"UBERON:0007023"},{"id":"T10","span":{"begin":141,"end":151},"obj":"SP_7"}],"text":"The aim of this study is to evaluate the efficacy and safety of human anti-SARS-CoV-2 convalescent plasma in hospitalized adults with severe SARS-CoV-2 infection."}

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T2","span":{"begin":99,"end":105},"obj":"Body_part"}],"attributes":[{"id":"A2","pred":"fma_id","subj":"T2","obj":"http://purl.org/sig/ont/fma/fma62970"}],"text":"The aim of this study is to evaluate the efficacy and safety of human anti-SARS-CoV-2 convalescent plasma in hospitalized adults with severe SARS-CoV-2 infection."}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T3","span":{"begin":75,"end":83},"obj":"Disease"},{"id":"T4","span":{"begin":141,"end":149},"obj":"Disease"},{"id":"T5","span":{"begin":152,"end":161},"obj":"Disease"}],"attributes":[{"id":"A3","pred":"mondo_id","subj":"T3","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"},{"id":"A4","pred":"mondo_id","subj":"T4","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"},{"id":"A5","pred":"mondo_id","subj":"T5","obj":"http://purl.obolibrary.org/obo/MONDO_0005550"}],"text":"The aim of this study is to evaluate the efficacy and safety of human anti-SARS-CoV-2 convalescent plasma in hospitalized adults with severe SARS-CoV-2 infection."}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T7","span":{"begin":4,"end":7},"obj":"http://purl.obolibrary.org/obo/PR_000001343"},{"id":"T8","span":{"begin":64,"end":69},"obj":"http://purl.obolibrary.org/obo/NCBITaxon_9606"},{"id":"T9","span":{"begin":99,"end":105},"obj":"http://purl.obolibrary.org/obo/UBERON_0001969"}],"text":"The aim of this study is to evaluate the efficacy and safety of human anti-SARS-CoV-2 convalescent plasma in hospitalized adults with severe SARS-CoV-2 infection."}

{"project":"LitCovid-sentences","denotations":[{"id":"T4","span":{"begin":0,"end":162},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"The aim of this study is to evaluate the efficacy and safety of human anti-SARS-CoV-2 convalescent plasma in hospitalized adults with severe SARS-CoV-2 infection."}

{"project":"LitCovid-PD-HP","denotations":[{"id":"T1","span":{"begin":134,"end":161},"obj":"Phenotype"}],"attributes":[{"id":"A1","pred":"hp_id","subj":"T1","obj":"http://purl.obolibrary.org/obo/HP_0033141"}],"text":"The aim of this study is to evaluate the efficacy and safety of human anti-SARS-CoV-2 convalescent plasma in hospitalized adults with severe SARS-CoV-2 infection."}

{"project":"LitCovid-PubTator","denotations":[{"id":"9","span":{"begin":64,"end":69},"obj":"Species"},{"id":"10","span":{"begin":75,"end":85},"obj":"Species"},{"id":"11","span":{"begin":141,"end":161},"obj":"Disease"}],"attributes":[{"id":"A9","pred":"tao:has_database_id","subj":"9","obj":"Tax:9606"},{"id":"A10","pred":"tao:has_database_id","subj":"10","obj":"Tax:2697049"},{"id":"A11","pred":"tao:has_database_id","subj":"11","obj":"MESH:C000657245"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"The aim of this study is to evaluate the efficacy and safety of human anti-SARS-CoV-2 convalescent plasma in hospitalized adults with severe SARS-CoV-2 infection."}